London
· Delayed Price · Currency is GBP · Price in GBXMaxCyte Statistics
Total Valuation
MaxCyte has a market cap or net worth of GBP 300.24 million. The enterprise value is 190.41 million.
| Market Cap | 300.24M |
| Enterprise Value | 190.41M |
Important Dates
The last earnings date was Friday, September 20, 2024.
| Earnings Date | Sep 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MaxCyte has 105.35 million shares outstanding. The number of shares has increased by 1.53% in one year.
| Shares Outstanding | 105.35M |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | +0.53% |
| Owned by Insiders (%) | 1.28% |
| Owned by Institutions (%) | 63.96% |
| Float | 96.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.24 |
| PB Ratio | 1.71 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.79 |
| EV / Sales | 5.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.48 |
Financial Position
The company has a current ratio of 14.31, with a Debt / Equity ratio of 0.08.
| Current Ratio | 14.31 |
| Quick Ratio | 13.19 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.73 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -15.33% and return on invested capital (ROIC) is -11.64%.
| Return on Equity (ROE) | -15.33% |
| Return on Assets (ROA) | -11.07% |
| Return on Capital (ROIC) | -11.64% |
| Revenue Per Employee | 251,430 |
| Profits Per Employee | -196,047 |
| Employee Count | 143 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 0.47 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.29% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +14.29% |
| 50-Day Moving Average | 310.66 |
| 200-Day Moving Average | 343.50 |
| Relative Strength Index (RSI) | 34.52 |
| Average Volume (20 Days) | 22,780 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MaxCyte had revenue of GBP 35.95 million and -28.03 million in losses. Loss per share was -0.27.
| Revenue | 35.95M |
| Gross Profit | 31.79M |
| Operating Income | -36.63M |
| Pretax Income | -28.03M |
| Net Income | -28.03M |
| EBITDA | -33.17M |
| EBIT | -36.63M |
| Loss Per Share | -0.27 |
Balance Sheet
The company has 124.49 million in cash and 14.66 million in debt, giving a net cash position of 109.83 million or 1.04 per share.
| Cash & Cash Equivalents | 124.49M |
| Total Debt | 14.66M |
| Net Cash | 109.83M |
| Net Cash Per Share | 1.04 |
| Equity (Book Value) | 175.08M |
| Book Value Per Share | 1.67 |
| Working Capital | 129.27M |
Cash Flow
In the last 12 months, operating cash flow was -17.93 million and capital expenditures -2.16 million, giving a free cash flow of -20.09 million.
| Operating Cash Flow | -17.93M |
| Capital Expenditures | -2.16M |
| Free Cash Flow | -20.09M |
| FCF Per Share | -0.19 |
Margins
Gross margin is 88.43%, with operating and profit margins of -101.88% and -77.97%.
| Gross Margin | 88.43% |
| Operating Margin | -101.88% |
| Pretax Margin | -77.97% |
| Profit Margin | -77.97% |
| EBITDA Margin | -92.25% |
| EBIT Margin | -101.88% |
| FCF Margin | -55.87% |
Dividends & Yields
MaxCyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.53% |
| Shareholder Yield | -1.53% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MaxCyte has an Altman Z-Score of 7.97.
| Altman Z-Score | 7.97 |
| Piotroski F-Score | n/a |